SHG · Healthcare
Biotechnology
Suzhou Novoprotein Scientific Co. Ltd. A (688137) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.81B, P/E ratio is 18.00, net margin is -50.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Suzhou Novoprotein Scientific Co. Ltd. A (688137) has a reported market cap of $2.81B (data as of 2026-03-29).
The price-to-earnings (P/E) ratio for Suzhou Novoprotein Scientific Co. Ltd. A (688137) is 18.00 (data as of 2026-03-29).
Dividend yield is not available in the current snapshot for Suzhou Novoprotein Scientific Co. Ltd. A (688137). Check the MyAverix Finance app for the latest dividend data.
Suzhou Novoprotein Scientific Co. Ltd. A (688137) is classified in the Healthcare sector (Biotechnology industry).
688137 is listed on SHG.
Suzhou Novoprotein Scientific Co. Ltd. A (688137) reports a net margin of -50.3% (data as of 2026-03-29).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.